Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorg Petersen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Hepatology|December 16, 2014
Do we need more nucleos(t)ide analogs for the treatment of chronic hepatitis B?Jorg Petersen
Hepatology (Baltimore, Md.)|December 1, 2005
Hepatitis B virus cccDNA clearance: killing for curing?Maura Dandri, Jorg Petersen
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?Jorg Petersen, Maura Dandri
Best Practice & Research. Clinical Gastroenterology|August 5, 2017
Hepatitis B virus infectionHarry L A Janssen, Henry Lik Yuen Chan, Jorg Petersen
Antiviral Therapy|September 13, 2006
Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBVKarsten Wursthorn, Peter Buggisch, Marc Lutgehetmann, et al.
Journal of Hepatology|July 21, 2009
Control of cccDNA function in hepatitis B virus infectionMassimo Levrero, Teresa Pollicino, Jorg Petersen, et al.
BMJ Open|June 14, 2019
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling studyQiushi Chen, Turgay Ayer, Emily Bethea, et al.
Journal of Hepatology|November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort studyJorg Petersen, Vlad Ratziu, Maria Buti, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infectionKris V Kowdley, Vinay Sundaram, Christie Y Jeon, et al.
Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Hepatology|December 16, 2014
Do we need more nucleos(t)ide analogs for the treatment of chronic hepatitis B?Jorg Petersen
Hepatology (Baltimore, Md.)|December 1, 2005
Hepatitis B virus cccDNA clearance: killing for curing?Maura Dandri, Jorg Petersen
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?Jorg Petersen, Maura Dandri
Best Practice & Research. Clinical Gastroenterology|August 5, 2017
Hepatitis B virus infectionHarry L A Janssen, Henry Lik Yuen Chan, Jorg Petersen
Antiviral Therapy|September 13, 2006
Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBVKarsten Wursthorn, Peter Buggisch, Marc Lutgehetmann, et al.
Journal of Hepatology|July 21, 2009
Control of cccDNA function in hepatitis B virus infectionMassimo Levrero, Teresa Pollicino, Jorg Petersen, et al.
BMJ Open|June 14, 2019
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling studyQiushi Chen, Turgay Ayer, Emily Bethea, et al.
Journal of Hepatology|November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort studyJorg Petersen, Vlad Ratziu, Maria Buti, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infectionKris V Kowdley, Vinay Sundaram, Christie Y Jeon, et al.
Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.
Pageof 1